Bioalmanac
5-Amino-1MQ
5-Amino-1-methylquinolinium · 5A1MQ
An oral NNMT inhibitor with striking results in obese mice and no human data whatsoever. Not a peptide, despite where it is sold.
Storage
- Freeze-dried powder
- Capsules or powder at room temperature, dry and out of direct light.
- After mixing
- Not applicable. This is taken orally, not reconstituted.
Dose ranges reported in sources
Descriptions of what sources report, not recommendations.
| Goal | Range | Frequency | Source |
|---|---|---|---|
| Commonly sold capsule strength | 50000–150000 mcg | Once daily, often described in courses of several weeks | Manufacturer |
When to stop
- Any allergic response: rash, hives, facial swelling or difficulty breathing. Seek urgent care.
- Yellowing of the skin or eyes, dark urine, or pain in the upper right abdomen. NNMT is highly expressed in the liver, and nothing establishes what inhibiting it there does.
- Persistent nausea, headache or fatigue.
- Any new lump or unexplained persistent symptom.
Use your browser’s print dialog and choose “Save as PDF”. This block is hidden when printed.